New inhibitors of the PI3K-Akt-mTOR pathway: insights into mTOR signaling from a new generation of Tor Kinase Domain Inhibitors (TORKinibs)

ME Feldman, KM Shokat - Phosphoinositide 3-kinase in Health and …, 2011 - Springer
Abstract mTOR (mammalian Target of Rapamycin) is the hub of the phosphoinositide 3-
Kinase (PI3-K)→ Akt→ mTOR pathway, which is one of the most commonly mutated …

[PDF][PDF] New Inhibitors of the PI3K-Akt-mTOR Pathway: Insights into mTOR Signaling from a New Generation of Tor Kinase Domain Inhibitors (TORKinibs)

ME Feldman, KM Shokat - … Further volumes can be found at …, 2010 - ndl.ethernet.edu.et
Abstract mTOR (mammalian Target of Rapamycin) is the hub of the phosphoinositide 3-
Kinase (PI3-K)→ Akt→ mTOR pathway, which is one of the most commonly mutated …

[引用][C] New Inhibitors of the PI3K-Akt-mTOR Pathway: Insights into mTOR Signaling from a New Generation of Tor Kinase Domain Inhibitors (TORKinibs)

ME FELDMAN, KM SHOKAT - Current Topics in Microbiology …, 2010 - pascal-francis.inist.fr
New Inhibitors of the PI3K-Akt-mTOR Pathway: Insights into mTOR Signaling from a New
Generation of Tor Kinase Domain Inhibitors (TORKinibs) CNRS Inist Pascal-Francis CNRS …

New Inhibitors of the PI3K-Akt-mTOR Pathway: Insights into mTOR Signaling from a New Generation of Tor Kinase Domain Inhibitors (TORKinibs)

ME Feldman, KM Shokat - … published volumes Further volumes can be …, 2010 - Springer
Abstract mTOR (mammalian Target of Rapamycin) is the hub of the phosphoinositide 3-
Kinase (PI3-K)→ Akt→ mTOR pathway, which is one of the most commonly mutated …

[PDF][PDF] New Inhibitors of the PI3K-Akt-mTOR Pathway: Insights into mTOR Signaling from a New Generation of Tor Kinase Domain Inhibitors (TORKinibs)

ME Feldman, KM Shokat - 2010 - shokatlab.ucsf.edu
Abstract mTOR (mammalian Target of Rapamycin) is the hub of the phosphoinositide 3-
Kinase (PI3-K)! Akt! mTOR pathway, which is one of the most commonly mutated pathways …

New Inhibitors of the PI3K-Akt-mTOR Pathway: Insights into mTOR Signaling from a New Generation of Tor Kinase Domain Inhibitors (TORKinibs)

ME Feldman, KM Shokat - Phosphoinositide 3-kinase in Health and Disease - infona.pl
mTOR (mammalian Target of Rapamycin) is the hub of the phosphoinositide 3-Kinase (PI3-
K)→ Akt→ mTOR pathway, which is one of the most commonly mutated pathways in cancer …

New inhibitors of the PI3K-Akt-mTOR pathway: insights into mTOR signaling from a new generation of Tor Kinase Domain Inhibitors (TORKinibs).

ME Feldman, KM Shokat - Current Topics in Microbiology and …, 2010 - europepmc.org
mTOR (mammalian Target of Rapamycin) is the hub of the phosphoinositide 3-Kinase (PI3-
K)→ Akt→ mTOR pathway, which is one of the most commonly mutated pathways in cancer …

New Inhibitors of the PI3K-Akt-mTOR Pathway: Insights into mTOR Signaling from a New Generation of Tor Kinase Domain Inhibitors (TORKinibs)

ME Feldman, KM Shokat - … 3-kinase in Health and Disease …, 2010 - books.google.com
Abstract mTOR (mammalian Target of Rapamycin) is the hub of the phosphoinositide 3-
Kinase (PI3-K)! Akt! mTOR pathway, which is one of the most commonly mutated pathways …

New inhibitors of the PI3K-Akt-mTOR pathway: insights into mTOR signaling from a new generation of Tor Kinase Domain Inhibitors (TORKinibs)

ME Feldman, KM Shokat - Current topics in microbiology …, 2010 - pubmed.ncbi.nlm.nih.gov
mTOR (mammalian Target of Rapamycin) is the hub of the phosphoinositide 3-Kinase (PI3-
K)→ Akt→ mTOR pathway, which is one of the most commonly mutated pathways in cancer …

[引用][C] New Inhibitors of the PI3K-Akt-mTOR Pathway: Insights into mTOR Signaling from a New Generation of Tor Kinase Domain Inhibitors (TORKinibs)

ME FELDMAN, KM SHOKAT - Current topics in microbiology and …, 2010 - Springer